Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $1.72 and last traded at $1.71, with a volume of 35748 shares traded. The stock had previously closed at $1.65.
BioRestorative Therapies Stock Up 3.6 %
The company has a fifty day moving average price of $1.61 and a 200-day moving average price of $1.52. The stock has a market capitalization of $2.80 billion, a P/E ratio of -1.60 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Ride Out The Recession With These Dividend Kings
- Intuitive Surgical Stock Outperforms Market: Highs on the Horizon
- Following Congress Stock Trades
- Has This Leading Tech Stock Halted the AI Surge?
- What is Short Interest? How to Use It
- Revolutionary Battery Stock Gains Momentum with 3D Silicon-Anodes
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.